D
Regeneron Pharmaceuticals, Inc. REGN
$744.83 $37.325.28%
Recommendation
Sell
Prev Close
$744.83
Volume
59
Avg Vol (90D)
899,934
Market Cap
$79.72B
Dividend & Yield
$0.88(0.12%)
52-Week Range
$642.00 - $1,211.20
P/E (TTM)
19.45
EPS (TTM)
$38.29
My Lists My Alerts
Rating
Reward
C
Fair
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Excellent
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
2/27/2025 - MarketBeat
Regeneron Pharmaceuticals Inc. Takes $845,000 Position in Adverum Biotechnologies, Inc. (NASDAQ:ADVM)
3/11/2025 - MarketBeat
Regeneron Pharmaceuticals Inc. Makes New $931,000 Investment in Adicet Bio, Inc. (NASDAQ:ACET)
3/11/2025 - MarketBeat
1,254,827 Shares in 2seventy bio, Inc. (NASDAQ:TSVT) Acquired by Regeneron Pharmaceuticals Inc.
3/11/2025 - MarketBeat
Regeneron Pharmaceuticals Inc. Buys Shares of 3,702,995 Intellia Therapeutics, Inc. (NASDAQ:NTLA)
3/11/2025 - MarketBeat
Regeneron Pharmaceuticals Inc. Buys New Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
3/11/2025 - MarketBeat
Daiwa Securities Group Inc. Acquires 1,278 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
3/11/2025 - MarketBeat
Regeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now
3/10/2025 - Insider Monkey
Regeneron Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your ...
3/10/2025 - GuruFocus
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. ...
3/10/2025 - GuruFocus
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
3/10/2025 - Business Wire
Levi & Korsinsky Notifies Shareholders of Regeneron Pharmaceuticals, Inc. ...
3/10/2025 - GuruFocus
American Assets Inc. Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
3/10/2025 - MarketBeat
M. Kulyk & Associates LLC Purchases Shares of 2,159 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
3/10/2025 - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Buys 209 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
3/10/2025 - Ticker Report
REGN LAWSUIT ALERT: The Gross Law Firm Notifies Regeneron Pharmaceuticals, Inc. ...
3/10/2025 - GuruFocus
Moran Wealth Management LLC Sells 2,538 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
3/10/2025 - MarketBeat
REGN LAWSUIT ALERT: The Gross Law Firm Notifies Regeneron Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
3/10/2025 - PR Newswire
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. ...
3/10/2025 - GuruFocus
Jones Financial Companies Lllp Has $578,000 Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
3/10/2025 - MarketBeat
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
3/10/2025 - PR Newswire
11 Oversold Blue Chip Stocks to Buy According to Hedge Funds
3/10/2025 - Insider Monkey
M. Kulyk & Associates LLC Makes New $1.54 Million Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
3/9/2025 - Ticker Report
Personal CFO Solutions LLC Increases Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
3/9/2025 - Ticker Report
Biogen Stock Is Mutating Into a Value Play
2/20/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$14.20B
EBITDA (TTM)
$4.60B
EBIT (TTM)
$4.12B
Net Income (TTM)
$4.41B
Balance Sheet
Total Assets (Q)
$37.76B
Total Debt (Q)
$2.94B
Total Liabilities (Q)
$8.41B
Book Value Per Share (Q)
$273.57
Cash Flow
Cash from Operations (TTM)
$4.42B
Cash from Investing (TTM)
-$2.47B
Cash from Financing (TTM)
-$2.20B
Net Change in Cash (TTM)
-$248.80M
Filings
Filing Date
Wednesday, February 5, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
0.41
7-Day Total Return
6.60%
30-Day Total Return
8.92%
60-Day Total Return
-4.20%
90-Day Total Return
-19.69%
Year to Date Total Return
4.28%
1-Year Total Return
-22.67%
2-Year Total Return
-0.87%
3-Year Total Return
16.06%
5-Year Total Return
60.49%
52-week Low
Feb 04, 2025 - $642.00
52-week High
Aug 27, 2024 - $1,211.20
Valuation
Market Cap
$79.72B - Large Cap
Enterprise Value
$64.74B
Price/Sales (TTM)
5.97
Price/Book (Q)
2.72
Dividends and Shares
Shares Outstanding
113.80M
Dividend Per Share (Most Recent)
$0.88
Dividend Per Share (TTM)
$0.88
Corporate Info
Website
www.regeneron.com
Phone Number
914 847 7000
Address
777 Old Saw Mill River Road
Tarrytown, NY 10591-6707
Country
United States
Year Founded
1988
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection to... more
NASDAQ 03/10/2025 4:00PM Eastern Quotes delayed
Weiss Ratings